Terbinafine inhibits endothelial cell migration through suppression of the Rho-mediated pathway

Molecular Cancer Therapeutics

Volumn 5, Issue 12, 2006, Pages 3130-3138

  Ho, Pei Yin ^a   Zhong, Wen Bin ^b   Ho, Yan Soon ^a   Lee, Wen Sen ^a,b  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; COLLAGEN; FARNESOL; FIBRONECTIN; FOCAL ADHESION KINASE; GELATINASE A; GELATINASE B; GERANYLGERANIOL; GERANYLGERANYL PYROPHOSPHATE; GUANINE NUCLEOTIDE BINDING PROTEIN; MESSENGER RNA; PAXILLIN; PROTEIN RHOC; RAS PROTEIN; RHO FACTOR; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; RHOB GUANINE NUCLEOTIDE BINDING PROTEIN; TERBINAFINE; UNCLASSIFIED DRUG;

ANTIANGIOGENIC ACTIVITY; ARTICLE; CELL ADHESION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; HUMAN; HUMAN CELL; METABOLIC INHIBITION; MIGRATION INHIBITION; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UMBILICAL VEIN; VASCULAR ENDOTHELIUM; WESTERN BLOTTING;

AMIDES; ANGIOGENESIS INHIBITORS; CELL ADHESION; CELL MOVEMENT; ENDOTHELIAL CELLS; ENZYME INHIBITORS; EXTRACELLULAR MATRIX; FOCAL ADHESION KINASE 1; HUMANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NAPHTHALENES; PAXILLIN; PHOSPHORYLATION; PYRIDINES; RAS PROTEINS; RHOA GTP-BINDING PROTEIN; RNA, MESSENGER;

EID: 33846188492     PISSN: 15357163     EISSN: None     Source Type: Journal    
DOI: 10.1158/1535-7163.MCT-06-0457     Document Type: Article

References (41)

1. Carmeliet P. Angiogenesis in health and disease. Nat Med 2003;9: 653-60.
2. Gupta MK, Qin RY. Mechanism and its regulation of tumor-induced angiogenesis. World J Gastroenterol 2003;9:1144-55.
3. Munoz-Chapuli R, Quesada AR, Angel Medina M. Angiogenesis and signal transduction in endothelial cells. Cell Mol Life Sci 2004;61: 2224-43.
4. Kalebic T, Garbisa S, Glaser B, Liotta LA. Basement membrane collagen: degradation by migrating endothelial cells. Science 1983;221: 281-3.
5. Bellon G, Martiny L, Robinet A. Matrix metalloproteinases and matrikines in angiogenesis. Crit Rev Oncol Hematol 2004;49:203-20.
6. Bussolino F, Mantovani A, Persico G. Molecular mechanisms of blood vessel formation. Trends Biochem Sci 1997;22:251-6.
7. 1 p53-associated cell cycle arrest. Int J Cancer 2003;106:125-37.
8. Ho PY, Liang YC, Ho YS, Chen CT, Lee WS. Inhibition of human vascular endothelial cells proliferation by terbinafine. Int J Cancer 2004; 111:51-9.
9. Sulochana KN, Fan H, Jois S, et al. Peptides derived from human decorin leucine-rich repeat 5 inhibit angiogenesis. J Biol Chem 2005;280: 27935-48.
10. Liu HJ, Lin PY, Lee JW, Hsu HY, Shih WL. Retardation of cell growth by avian reovirus p17 through the activation of p53 pathway. Biochem Biophys Res Commun 2005;336:709-15.
11. Pilorget A, Annabi B, Bouzeghrane F, Marvaldi J, Luis J, Beliveau R. Inhibition of angiogenic properties of brain endothelial cells by platelet-derived sphingosine-1-phosphate. J Cereb Blood Flow Metab 2005;25: 1171-82.
12. Uchima Y, Sawada T, Nishihara T, Maeda K, Ohira M, Hirakawa K. Inhibition and mechanism of action of a protease inhibitor in human pancreatic cancer cells. Pancreas 2004;29:123-31.
13. Arkell J, Jackson CJ. Constitutive secretion of MMP9 by early-passage cultured human endothelial cells. Cell Biochem Funct 2003;21: 381-6.
14. Lee SK, Kim JM, Lee MY, et al. Confirmation of a linkage between H-Ras and MMP-13 expression as well as MMP-9 by chemical genomic approach. Int J Cancer 2006;9:2172-81.
15. Wu WT, Chen CN, Lin CI, Chen JH, Lee H. Lysophospholipids enhance matrix metalloproteinase-2 expression in human endothelial cells. Endocrinology 2005;146:3387-400.
16. Tse AK, Wan CK, Shen XL, Yang M, Fong WF. Honokiol inhibits TNF-α-stimulated NF-κB activation and NF-κB-regulated gene expression through suppression of IKK activation. Biochem Pharmacol 2005;70: 1443-57.
17. Hood JD, Cheresh DA. Role of integrins in cell invasion and migration. Nat Rev Cancer 2002;2:91-100.
18. Keledjian K, Garrison JB, Kyprianou N. Doxazosin inhibits human vascular endothelial cell adhesion, migration, and invasion. J Cell Biochem 2005;94:374-88.
19. Wu MH. Endothelial focal adhesions and barrier function. J Physiol 2005;569:359-66.
20. 1 induces apoptosis of angiogenic endothelial cells on type I collagen. Vascul Pharmacol 2003;40:77-89.
21. McTaggart SJ. Isoprenylated proteins. Cell Mol Life Sci 2006;63: 255-67.
22. Darkes MJ, Scott LJ, Goa KL. Terbinafine: a review of its use in onychomycosis in adults. Am J Clin Dermatol 2003;4:39-65.
23. Rikitake Y, Liao JK. Rho GTPases, statins, and nitric oxide. Circ Res 2005;97:1232-5.
24. Bouterfa HL, Sattelmeyer V, Czub S, Vordermark D, Roosen K, Tonn JC. Inhibition of Ras farnesylation by lovastatin leads to downregulation of proliferation and migration in primary cultured human glioblastoma cells. Anticancer Res 2000;20:2761-71.
25. Abedi H, Zachary I. Signalling mechanisms in the regulation of vascular cell migration. Cardiovasc Res 1995;30:544-56.
26. Seabra MC. Membrane association and targeting of prenylated Ras-like GTPases. Cell Signal 1998;10:167-72.
27. Ridley AJ, Hall A. The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell 1992;70:389-99.
28. Ridley AJ, Schwartz MA, Burridge K, et al. Cell migration: integrating signals from front to back. Science 2003;302:1704-9.
29. Van Aelst L, D'Souza-Schorey C. Rho GTPases and signaling networks. Genes Dev 1997;11:2295-22.
30. Fryer BH, Field J. Rho, Rac, Pak, and angiogenesis: old roles and newly identified responsibilities in endothelial cells. Cancer Lett 2005; 229:13-23.
31. Soga N, Namba N, McAllister S, et al. Rho family GTPases regulate VEGF-stimulated endothelial cell motility. Exp Cell Res 2001;269:73-87.
32. Wherlock M, Gampel A, Futter C, Mellor H. Farnesyltransferase inhibitors disrupt EGF receptor traffic through modulation of the RhoB GTPase. J Cell Sci 2004;117:3221-31.
33. Fritz G, Kaina B. rhoB encoding a UV-inducible Ras-related small GTP-binding protein is regulated by GTPases of the Rho family and independent of JNK, ERK, and p38 MAP kinase. J Biol Chem 1997;272: 30637-44.
34. Wheeler AP, Ridley AJ. Why three Rho proteins? RhoA, RhoB, RhoC, and cell motility. Exp Cell Res 2004;301:43-9.
35. Pepper MS. Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis. Arterioscler Thromb Vasc Biol 2001;21:1104-17.
36. Abecassis I, Olofsson B, Schmid M, Zalcman G, Karniguian A. RhoA induces MMP-9 expression at CD44 lamellipodial focal complexes and promotes HMEC-1 cell invasion. Exp Cell Res 2003;291:363-76.
37. Zhuge Y, Xu J. Rac1 mediates type I collagen-dependent MMP-2 activation. Role in cell invasion across collagen barrier. J Biol Chem 2001; 276:16248-56.
38. Matsumoto Y, Tanaka K, Harimaya K, Nakatani F, Matsuda S, Iwamoto Y. Small GTP-binding protein, Rho, both increased and decreased cellular motility, activation of matrix metalloproteinase 2, and invasion of human osteosarcoma cells. Jpn J Cancer Res 2001;92:429-38.
39. Hauck CR, Hsia DA, Schlaepfer DD. The focal adhesion kinase-a regulator of cell migration and invasion. IUBMB Life 2002;53:115-9.
40. Cohen LA, Guan JL. Mechanisms of focal adhesion kinase regulation. Curr Cancer Drug Targets 2005;5:629-43.
41. Flinn HM, Ridley AJ. Rho stimulates tyrosine phosphorylation of focal arhesion kinase, p130, and paxillin. J Cell Sci 1996;109:1133-41.